IDYA - Company ID 0001676725
The table below shows IDEAYA Biosciences, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$71.10M | -$247.58M | -$115.22M | -$87.17M | -$55.78M | $55.46M |
| Capital expenditure | $2.37M | $3.86M | $2.37M | $3.44M | $2.64M | $493.00K |
| Investing cash flow | $69.98M | -$502.56M | -$158.46M | -$33.40M | -$69.67M | -$146.24M |
| Dividends paid | - | - | - | - |
IDEAYA Biosciences, Inc. reported operating cash flow of -$71.10M for fiscal year 2025. That is up 71.3% from -$247.58M in fiscal 2024. Over the 9 fiscal years shown, operating cash flow declined from -$12.22M (FY 2017) to -$71.10M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $29.78M | $677.55M | $362.72M | $97.17M | $145.45M | $128.75M |